The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study.

European journal of haematology(2023)

引用 2|浏览12
暂无评分
摘要
Referring patients with chemotherapy-sensitive disease in PR directly to HCT is associated with better OS compared to those receiving additional lines of treatment.
更多
查看译文
关键词
B-cell,autologous hematopoietic cell transplantation,diffuse large cell,lymphoma,partial response,refractory,relapse,second salvage
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要